Practice Management News

A joint letter from six major medical organizations calls on Congress to ensure patients can access affordable, quality health care.

Shineco Inc. announced it has been granted a United States Patent and Trademark Office patent and FDA marketing approval for its in-situ fecal specimen sampling device intended for stool test sample collection..

On Friday, Dec. 2, 2022, the government snuck out an FAQ delaying implementation of the requirement that good faith estimates under the No Surprises Act must include information from co-providers.

The Liver Meeting 2022 delivered the latest research and developments on a variety of topics, including acute hepatitis in children, treatment for hepatitis-related cirrhosis and liver disease mortality during the COVID-19 pandemic.

Following FDA approval of the first fecal microbiota biotherapeutics for recurrent Clostridoides difficile, the American Gastroenterological Association summarized what this means for gastroenterologists and patients going forward.

Patients frequently misunderstand physician phrases and assign opposite meanings of what was intended, leading to confusion about health outcomes, a study published in JAMA Network Open reported.

Practices may find this short primer on state pass-through entity election and year-end tax tips helpful to determine whether they can benefit from a state tax strategy or create some tax savings before Jan. 1, 2023.

It has long been said that the best way to treat obesity is to eat a healthy, reduced-calorie diet and exercise regularly.

CHARLOTTE, N.C. — Healio Gastroenterology unveiled its fifth annual Disruptive Innovators Awards recipients during a prestigious awards ceremony at the American College of Gastroenterology Annual Scientific Meeting.

FDA granted fast track designation to Palisade Bio’s broad-spectrum serine protease inhibitor, LB1148, for expedited return of bowel function following gastrointestinal surgery, according to a manufacturer release.